plasminogen Antibodies

Santa Cruz Biotechnology features a diverse variety of plasminogen monoclonal antibodies for various research applications. Plasminogen monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Plasminogen is a crucial component involved in the fibrinolytic system, playing a key role in the breakdown of fibrin in blood clots. The conversion of plasminogen to plasmin is essential for tissue remodeling and wound healing, making it a significant focus in studies related to cardiovascular diseases and cancer metastasis. Understanding plasminogen function and regulation can provide insights into various pathological conditions and therapeutic strategies. Plasminogen research has revealed important mechanisms in blood clot dissolution and tissue repair processes. Current investigations continue to uncover new roles for plasminogen in different biological pathways and disease states. Ongoing research utilizing plasminogen monoclonal antibodies from Santa Cruz Biotechnology contributes to advancing our understanding of cardiovascular health, cancer biology, and potential therapeutic interventions.